Mitsuhiko Iwamoto

Osaka, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 46 publications

Predictors of Discontinuation of Eribulin Therapy for Metastatic Breast Cancer: A Retrospective Cohort Study.

Predictors of Discontinuation of Eribulin Therapy for Metastatic Breast Cancer: A Retrospective Cohort Study.

Journal: Anticancer research
Published: May 21, 2026

Semi-Urgent Totally Extraperitoneal Repair for Inguinal Hernia Causing Insufficient Intraperitoneal Exchange in a Patient on Peritoneal Dialysis: A Case Report.

Semi-Urgent Totally Extraperitoneal Repair for Inguinal Hernia Causing Insufficient Intraperitoneal Exchange in a Patient on Peritoneal Dialysis: A Case Report.

Journal: Surgical case reports
Published: January 28, 2026

A Case of Gastric Metastasis from Breast Cancer Detected 12 Years after Surgery

A Case of Gastric Metastasis from Breast Cancer Detected 12 Years after Surgery

Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: December 24, 2025

Phytochrome A deficiency improves nutrient ion uptake and productivity in rice (Oryza sativa L.).

Phytochrome A deficiency improves nutrient ion uptake and productivity in rice (Oryza sativa L.).

Journal: Plant biology (Stuttgart, Germany)
Published: November 18, 2025

Successful Ninth-Line Therapy with Trastuzumab Deruxtecan in Recurrent Breast Cancer with Low HER2 Expression-A Case Report

Successful Ninth-Line Therapy with Trastuzumab Deruxtecan in Recurrent Breast Cancer with Low HER2 Expression-A Case Report

Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: November 18, 2025

ASO Visual Abstract: ESR1 Expression Negatively Correlates with Immune Cell Infiltration and Response to Immune Checkpoint Inhibitors in ER-Positive HER2-Negative Breast Cancer.

ASO Visual Abstract: ESR1 Expression Negatively Correlates with Immune Cell Infiltration and Response to Immune Checkpoint Inhibitors in ER-Positive HER2-Negative Breast Cancer.

Journal: Annals of surgical oncology
Published: October 22, 2025

ASO Author Reflections: Predictors of Immune Checkpoint Inhibitor Response in ER+/HER2- Breast Cancer: A New Role for ESR1?

ASO Author Reflections: Predictors of Immune Checkpoint Inhibitor Response in ER+/HER2- Breast Cancer: A New Role for ESR1?

Journal: Annals of surgical oncology
Published: September 03, 2025

A Case of Breast Cancer with Bone Marrow Metastasis in a Patient with a History of Systemic Lupus Erythematosus and Autoimmune Hemolytic Anemia

A Case of Breast Cancer with Bone Marrow Metastasis in a Patient with a History of Systemic Lupus Erythematosus and Autoimmune Hemolytic Anemia

Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: August 21, 2025

Malignant adenomyoepithelioma with HRAS G13R mutation: A case report.

Malignant adenomyoepithelioma with HRAS G13R mutation: A case report.

Journal: Oncology letters
Published: July 30, 2025

Non-surgical breast-conserving treatment using Kochi oxydol-radiation therapy for unresectable carcinomas II for patients with stage 0 to IIIC breast cancer.

Non-surgical breast-conserving treatment using Kochi oxydol-radiation therapy for unresectable carcinomas II for patients with stage 0 to IIIC breast cancer.

Journal: Oncology letters
Published: July 28, 2025

ESR1 Expression Negatively Correlates with Immune Cell Infiltration and Response to Immune Checkpoint Inhibitors in Estrogen Receptor-Positive/HER2-Negative Breast Cancer.

ESR1 Expression Negatively Correlates with Immune Cell Infiltration and Response to Immune Checkpoint Inhibitors in Estrogen Receptor-Positive/HER2-Negative Breast Cancer.

Journal: Annals of surgical oncology
Published: June 16, 2025

Predictors of abemaciclib discontinuation in patients with breast cancer: a multicenter retrospective cohort study.

Predictors of abemaciclib discontinuation in patients with breast cancer: a multicenter retrospective cohort study.

Journal: BMC cancer
Published: July 23, 2024
Showing 1-12 of 46

Last Updated: 09/26/2026